compounding pharmacies

News

HHS doubles down on controversial peptides plan

HHS unveils an enforcement holiday to manufacture of unapproved peptides - before the FDA decides if they should be allowed in compounded medicines.

News

Compounded tirzepatide recalled after FDA warning

A compounded version of Eli Lilly's injectable weight-loss and diabetes therapy tirzepatide has been recalled from sale due to sterility concerns.

News

Re-rostered FDA committee backs peptide compounding

Against the advice of FDA staff scientists, an advisory committee has narrowly voted in support of looser restrictions on compounded peptides.

News

FDA ramps up its pushback against compounded GLP-1s

In a move that will please Novo Nordisk and Eli Lilly, the FDA sent warnings to 30 telehealth firms, accusing them of illegally marketing GLP-1 drugs.

News

Black and white image of a white flag of surrender

Novo Nordisk rises as Hims & Hers backs down on oral GLP-1

Novo Nordisk's battered stock enjoyed a reprieve after Hims & Hers abandoned plans to launch a compounded version of the new Wegovy pill.

News

Hims & Hers copies Novo Nordisk's new Wegovy pill

Competition has already arrived for Novo Nordisk's Wegovy pill, as telehealth company Hims & Hers launches a compounded version.

HHS doubles down on controversial peptides plan

Compounded tirzepatide recalled after FDA warning

Re-rostered FDA committee backs peptide compounding

FDA ramps up its pushback against compounded GLP-1s

Novo Nordisk rises as Hims & Hers backs down on oral GLP-1

Hims & Hers copies Novo Nordisk's new Wegovy pill

Oura smart ring to be used in weight-loss outcomes trial

Discover a new era of healthcare panel engagement: Grounded ...

compounding pharmacies

Editor's Picks